NSE filing, NSE: AFIL. Summary written from the filing by ALFA Finder's alert engine.
Akme Fintrade (India) Ltd: key numbers
- Share price
- ₹7.00
- Market cap
- ₹304.5 Cr
- Revenue (annual)
- ₹148.8 Cr
- Net profit (annual)
- ₹42.32 Cr
- P/E (TTM)
- 6.6×Sector 20.3×
- Promoter holding
- 38.94%-0.08% QoQ
- FII holding
- 0.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Akme Fintrade (India) Ltd
All →Akme Fintrade (India) Share Pledge
Promoter Manju Devi Jain pledged 1,14,50,000 Akme Fintrade shares (2.55%) to Upsurge Investment & Finance. Post-pledge encumbrance rises to 4.43% of share capital.
Akme Fintrade (India) Results Update
Akme Fintrade's press release shows H1 FY27 PAT up 19% and AUM crossing Rs. 1,000 crore. The unaudited results were approved by the board.
Akme Fintrade (India) Q2 FY27 Results: Net Profit ₹11.9 Cr, Up 19.0% YoY
Akme Fintrade (India) Ltd reported revenue from operations of ₹45.5 Cr (+30.4% YoY) and net profit of ₹11.9 Cr (+19.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹11.9 Cr · +19.0% YoY
Akme Fintrade (India) Preferential Issue
Akme Fintrade received NSE and BSE trading approval for 82 lakh preferentially-issued equity shares. Listed capital rose to Rs. 44.79 Crore post-approval.
Akme Fintrade (India) Convertible Warrants
Akme Fintrade received NSE and BSE trading approval for 82 lakh equity shares from preferential warrant conversion. Total listed capital rose to Rs. 44.79 crore post-allotment.
Akme Fintrade (India) Board Meeting Date
Akme Fintrade intimated that its Board will meet on October 30, 2026 to approve unaudited financial results for Q2 H1 FY27. Trading window remains closed until 48 hours post-announcement.
Other business update announcements
All →Aarti Drugs Business Update
Aarti Drugs disclosed that the US FDA inspected its subsidiary Pinnacle Life Science's Baddi plant on 2-6 November 2026 and issued three Form 483 observations. The company states there is no financial or operational impact.
GSM Foils Business Update
GSM Foils Limited reported Net Sales of Rs. 14,63,47,636 for October 2026, with April-October cumulative sales of Rs. 1,59,69,98,607. The monthly sales update is filed under Regulation 30.
- Value
- ₹14.63 Cr
Runwal Enterprises Business Update
Runwal Enterprises adopted a fair disclosure code for unpublished price sensitive information under SEBI PIT Regulation 8. The code is hosted on the company website.
Mphasis Business Update
Mphasis's board approved amendments to its Code of Practices and Procedures for Fair Disclosure of UPSI. The amended code is published on the company website.
Kingfa Science & Technology (India) Business Update
Kingfa Science & Technology filed a Q2 FY2026-27 performance update deck with greetings, market outlook and industry auto-production data. No revenue/profit table, order, or transaction is disclosed, so it is routine investor material.
Supertex Industries Business Update
Supertex Industries approved leasing factory space and machinery to related party Silt Advanced Materials. The five-year lease pays Rs 10,000 monthly plus GST.
- Value
- ₹0.00 Cr
- Execution
- 5 years, effective 10.11.2026